|
US2017073775A1
|
|
Compositions and methods for prognosis of ovarian cancer
|
|
US2017016076A1
|
|
MiRNA expression signature in the classification of thyroid tumors
|
|
CN106460053A
|
|
MIRNA expression signature in classification of thyroid tumors
|
|
US2015099665A1
|
|
Methods for distinguishing between specific types of lung cancers
|
|
US2014315739A1
|
|
Gene expression signature for classification of tissue of origin of tumor samples
|
|
WO2014203189A1
|
|
Nanocarrier system for micrornas and uses thereof
|
|
US2014256789A1
|
|
Composition and methods for modulating cell proliferation and cell death
|
|
US2013259839A1
|
|
Gene expression signature for classification of tissue of origin of tumor samples
|
|
WO2013024469A1
|
|
Methods and compositions for diagnosis of alzheimer's desease
|
|
EP2714934A2
|
|
Methods and compositions for determining heart failure or a risk of heart failure
|
|
CN103764844A
|
|
Methods for lung cancer clasification
|
|
WO2012093384A1
|
|
Compositions and methods for treatment of ovarian cancer
|
|
EP2643479A2
|
|
Methods and materials for classification of tissue of origin of tumor samples
|
|
IL210713D0
|
|
Compositions and methods for determininig the prognosis of bladder urothelail cancer
|
|
IL209100D0
|
|
Methods for distinguishing between specific types of lung cancers
|
|
IL209097D0
|
|
Compositions and methods for prognosis of gastric cancer
|
|
IL209099D0
|
|
Compositions and methods for prognosis of ovarian cancer
|
|
WO2011021177A2
|
|
Compositions and methods for prognosis and treatment of prostate cancer
|
|
WO2011024157A1
|
|
Nucleic acid sequences related to cancer
|
|
IL206294D0
|
|
Methods and compositions for diagnosing complications of pregnacy
|
